150 related articles for article (PubMed ID: 2020920)
1. [Design and analysis of phase II trials in oncology with a group sequential method, the triangular test].
Bellissant E; Bénichou J; Chastang C
Therapie; 1991; 46(1):21-7. PubMed ID: 2020920
[TBL] [Abstract][Full Text] [Related]
2. Impact of a mis-specification of the response rate under standard treatment in sequential clinical trials.
Sébille V; Bellissant E
Fundam Clin Pharmacol; 2005 Oct; 19(5):569-78. PubMed ID: 16176336
[TBL] [Abstract][Full Text] [Related]
3. Designs for group sequential phase II clinical trials.
Chang MN; Therneau TM; Wieand HS; Cha SS
Biometrics; 1987 Dec; 43(4):865-74. PubMed ID: 3427171
[TBL] [Abstract][Full Text] [Related]
4. Phase II trials in cancer: present status and analysis methods.
Lee YJ
Drugs Exp Clin Res; 1986; 12(1-3):57-71. PubMed ID: 3732056
[TBL] [Abstract][Full Text] [Related]
5. Phase II multi-step planning methods in oncology: comparison, recommendations and potential applications.
Medioni J; de Rycke Y; Tournoux Facon C; Mallet A; Asselain B
Contemp Clin Trials; 2007 May; 28(3):249-57. PubMed ID: 17113357
[TBL] [Abstract][Full Text] [Related]
6. Optimal and minimax three-stage designs for phase II oncology clinical trials.
Chen K; Shan M
Contemp Clin Trials; 2008 Jan; 29(1):32-41. PubMed ID: 17544337
[TBL] [Abstract][Full Text] [Related]
7. Two-stage designs for phase II cancer trials with ordinal responses.
Stallard N; Cockey L
Contemp Clin Trials; 2008 Nov; 29(6):896-904. PubMed ID: 18703164
[TBL] [Abstract][Full Text] [Related]
8. Sample size re-estimation in group-sequential response-adaptive clinical trials.
Morgan CC
Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
[TBL] [Abstract][Full Text] [Related]
9. The group sequential triangular test for phase II cancer clinical trials.
Bellissant E; Bénichou J; Chastang C
Am J Clin Oncol; 1996 Aug; 19(4):422-30. PubMed ID: 8677918
[TBL] [Abstract][Full Text] [Related]
10. Alternative designs of phase II trials considering response and toxicity.
Jin H
Contemp Clin Trials; 2007 Jul; 28(4):525-31. PubMed ID: 17428744
[TBL] [Abstract][Full Text] [Related]
11. [Termination rules in therapeutic trials. Application of sequential methods in 2 clinical trials in hematology].
Bénichou J; Lepage E; Chastang C
Nouv Rev Fr Hematol (1978); 1987; 29(1):87-91. PubMed ID: 3473443
[TBL] [Abstract][Full Text] [Related]
12. Comparison of four sequential methods allowing for early stopping of comparative clinical trials.
Sebille V; Bellissant E
Clin Sci (Lond); 2000 May; 98(5):569-78. PubMed ID: 10781388
[TBL] [Abstract][Full Text] [Related]
13. A flexible multi-stage design for phase II oncology trials.
Tan MT; Xiong X
Pharm Stat; 2011; 10(4):369-73. PubMed ID: 22328328
[TBL] [Abstract][Full Text] [Related]
14. Sequential analysis of latent variables using mixed-effect latent variable models: Impact of non-informative and informative missing data.
Sébille V; Hardouin JB; Mesbah M
Stat Med; 2007 Nov; 26(27):4889-904. PubMed ID: 17576119
[TBL] [Abstract][Full Text] [Related]
15. Designs for efficient clinical trials.
Simon R
Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811
[TBL] [Abstract][Full Text] [Related]
16. Sequential designs for phase III clinical trials incorporating treatment selection.
Stallard N; Todd S
Stat Med; 2003 Mar; 22(5):689-703. PubMed ID: 12587100
[TBL] [Abstract][Full Text] [Related]
17. One-sample multiple testing procedure for phase II clinical trials.
Fleming TR
Biometrics; 1982 Mar; 38(1):143-51. PubMed ID: 7082756
[TBL] [Abstract][Full Text] [Related]
18. Symmetric group sequential test designs.
Emerson SS; Fleming TR
Biometrics; 1989 Sep; 45(3):905-23. PubMed ID: 2675998
[TBL] [Abstract][Full Text] [Related]
19. [Application of sequential methods in randomized clinical trials with censored response criteria].
Benichou J; Chastang C
Rev Epidemiol Sante Publique; 1986; 34(3):196-208. PubMed ID: 3786877
[TBL] [Abstract][Full Text] [Related]
20. [New trends in assessment in anticancer treatments by phase II clinical trials].
Medioni JR; Rycke YD; Asselain B
Bull Cancer; 2000 Jul; 87(7-8):551-6. PubMed ID: 10969213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
